Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dengue Virus Antigenic Peptides (DENV Antigenic Peptides)
- Target
- DENV Antigenic Peptides
- Molecular classification
- Peptide, Viral Protein Fragment, Antigen
01
Overview
Dengue virus antigenic peptides are short amino acid sequences derived from the structural and non-structural proteins of the dengue virus (DENV) that are recognized by the host immune system. These peptides can elicit antibody responses, making them valuable for diagnostics, vaccine development, and therapeutic antibody production. Key source proteins include the Envelope (E), Membrane/Pre-membrane (M/prM), Capsid (C), and non-structural protein NS1. They are primarily used as diagnostic biomarkers and in the development of immunotherapeutics.
- Other names
- Dengue E protein peptidesDengue NS1 peptidesDENV peptidesDengue virus-derived peptides
02
Mechanism of action
N/A
03
Biological functions
Antigen presentationImmune response elicitationDiagnostic biomarkerAntibody binding
04
Disease associations
InfectionDengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
05
Biomarkers
IgM antibodies to dengue peptidesIgG antibodies to dengue peptides
Beyond the preview
Go deeper on Dengue Virus Antigenic Peptides (DENV Antigenic Peptides).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dengue Virus Antigenic Peptides (DENV Antigenic Peptides).